Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bio Light Climbs Most in 4 Months on Acquisition Talks

Jan. 18 (Bloomberg) -- Bio Light Israeli Life Sciences Investments Ltd. rose the most in more than four months after the owner of companies that develop drugs and medical technology said an investor group is in talks to buy a controlling stake.

The shares surged 16 percent, the most since Sept. 6, to 0.428 shekel at the 4:30 p.m. close in Tel Aviv, giving the Ramat Gan-based company a market value of 40 million shekels ($11 million).

Investors led by Israel Makov are in discussions to purchase a 26.1 percent stake in Bio Light for about 10 million shekels, the company said in a statement to the Tel Aviv Stock Exchange today.

To contact the reporter on this story: Ronit Goodman in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.